Olema Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	811	768	99	377	1,804
Market Cap Growth	348.93%	675.28%	-73.72%	-79.10%	-
Enterprise Value	554	509	-103	93	1,465
PE Ratio	-	-7.95	-0.95	-5.30	-75.20
PB Ratio	3.39	3.03	0.50	1.33	5.34
P/FCF Ratio	-7.28	-9.18	-1.20	-7.22	-90.55
P/OCF Ratio	-7.29	-9.18	-1.21	-7.44	-90.81
EV/EBITDA Ratio	-3.95	-5.36	1.00	-1.34	-68.29
EV/EBIT Ratio	-3.89	-5.27	0.98	-1.31	-68.26
EV/FCF Ratio	-4.44	-6.08	1.25	-1.78	-73.56
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-0.02	-0.03	-0.02	-0.05	-
Debt / FCF Ratio	-0.03	-0.03	-0.03	-0.06	-
Quick Ratio	9.49	12.11	12.35	31.85	73.84
Current Ratio	9.61	12.33	12.62	32.23	74.62
Interest Coverage	-	-	-	-	-32.88
Return on Equity (ROE)	-42.90%	-44.70%	-45.70%	-23.20%	-14.60%
Return on Assets (ROA)	-39.30%	-41.00%	-43.00%	-22.60%	-14.00%
Return on Capital (ROIC)	-45.99%	-40.95%	-53.46%	-24.84%	-6.37%
Earnings Yield	-12.41%	-12.58%	-105.72%	-18.85%	-1.33%
FCF Yield	-10.87%	-10.89%	-83.16%	-13.86%	-1.10%
Buyback Yield / Dilution	-37.72%	-13.13%	-1.19%	-462.91%	-170.75%
Total Shareholder Return	-37.72%	-13.13%	-1.19%	-462.91%	-170.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).